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Abstract
Background: Tackling neonatal mortality is essential for the achievement of the child survival millennium 
development goal. There are just under 4 million neonatal deaths, accounting for 38% of the 10.8 million deaths 
among children younger than 5 years of age taking place each year; 99% of these occur in low- and middle-income 
countries where a large proportion of births take place at home, and where postnatal care for mothers and neonates is 
either not available or is of poor quality. WHO and UNICEF have issued a joint statement calling for governments to 
implement "Home visits for the newborn child: a strategy to improve survival", following several studies in South Asia 
which achieved substantial reductions in neonatal mortality through community-based approaches. However, their 
feasibility and effectiveness have not yet been evaluated in Africa. The Newhints study aims to do this in Ghana and to 
develop a feasible and sustainable community-based approach to improve newborn care practices, and by so doing 
improve neonatal survival.
Methods: Newhints is an integrated intervention package based on extensive formative research, and developed in 
close collaboration with seven District Health Management Teams (DHMTs) in Brong Ahafo Region. The core 
component is training the existing community based surveillance volunteers (CBSVs) to identify pregnant women and 
to conduct two home visits during pregnancy and three in the first week of life to address essential care practices, and 
to assess and refer very low birth weight and sick babies. CBSVs are supported by a set of materials, regular supervisory 
visits, incentives, sensitisation activities with TBAs, health facility staff and communities, and providing training for 
essential newborn care in health facilities.
Newhints is being evaluated through a cluster randomised controlled trial, and intention to treat analyses. The clusters
are 98 supervisory zones; 49 have been randomised for implementation of the Newhints intervention, with the other
49 acting as controls. Data on neonatal mortality and care practices will be collected from approximately 15,000 babies
through surveillance of women of child-bearing age in the 7 districts. Detailed process, cost and cost-effectiveness
evaluations are also being carried out.
Trial registration: http://www.clinicaltrials.gov (identifier NCT00623337)
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Although the child survival revolution of the 1980s led to
dramatic reductions in overall child mortality, it has had
little impact on deaths taking place in the first 28 days of
life (the neonatal period). There are just under 4 million
neonatal deaths, accounting for 38% of the 10.8 million
deaths among children younger than 5 years of age taking
place each year[1]; 99% of these occur in low- and mid-
dle-income countries[1]. Tackling neonatal mortality is
therefore essential if the millennium development goal of
reducing child mortality by two-thirds between 1990 and
2015 is to be achieved[1].
Common direct causes of neonatal deaths in develop-
ing countries are known: infections (pneumonia, neona-
tal tetanus, sepsis, and diarrhoea), asphyxia, birth injuries
and complications of preterm birth[1]. Indirect causes of
neonatal deaths such as low birth weight and hypo-
thermia are also important [2] as is the link between
maternal health and neonatal outcomes [1,2]. Postnatal
care for mothers and neonates in developing countries,
particularly when deliveries occur at home, is either not
available or is of poor quality. Interventions are urgently
needed, particularly those directed at improving family
newborn care practices and community level health ser-
vice delivery; the Lancet neonatal series suggests that 15-
32% of neonatal deaths could be prevented through pro-
motion of a few key practices: clean home delivery,
hygienic cord care, thermal care, early and exclusive
breastfeeding and care seeking for illness[3].
Trained community workers are considered by many to
be pivotal to newborn care in the community, as they can
act as catalysts for community actions and also be provid-
ers of care[4], and several studies in South Asia have
shown that substantial mortality reductions can be
achieved with this approach[5-8]. Projects in Nepal[9]
and Bolivia[10] have demonstrated that substantial
improvements in neonatal survival can also be achieved
through encouraging community organisation and par-
ticipation in women's groups.
Based on the successes from the studies in South Asia,
WHO and UNICEF have issued a joint statement calling
for governments to implement "Home visits for the new-
born child: a strategy to improve survival" [4]. However,
the feasibility and effectiveness of community approaches
to reduce newborn mortality have not yet been evaluated
in Africa, where the epidemiology of neonatal deaths and
the health system are very different from South Asia.
Progress in reducing neonatal mortality has been slower
in Sub-Saharan Africa than in any other region in the
world, and projections on percentage of skilled atten-
dance at delivery suggest that this will remain static at
just above 40% over the period to 2015[11]. Complemen-
tary strategies, such as delivering community-based
interventions, are urgently required[3]. This paper pres-
ents the protocol for a cluster randomised controlled trial
to evaluate the impact of such a community-based inter-
vention on newborn care practices and neonatal mortal-




To develop a feasible and sustainable community-based
approach in rural Ghana to improve newborn care prac-
tices and careseeking during pregnancy and childbirth,
and by so doing improve neonatal survival.
Primary objectives
1. To link with District Health Management Teams
(DHMTs) to develop a feasible and sustainable inter-
vention to improve newborn care practices and care-
seeking through training the current network of
community based surveillance volunteers (CBSVs) to
identify pregnant women in the community and to
conduct two home visits during pregnancy and three
in the first week of life of the neonate.
2. To evaluate the impact of these home visits on all
cause neonatal mortality.
3. To evaluate their impact on newborn care prac-
tices.
Secondary objectives
4. To assess the coverage and quality of the service
provided and the family and community response to
the service.
5. To assess the cost of implementing the interven-
tion, and the cost-effectiveness of any impact.
6. To evaluate whether the impact of the intervention
on neonatal mortality differs between home- and
facility-based deliveries.
7. To evaluate the impact of the intervention on age-
and cause-specific neonatal mortality.
Setting
The Newhints trial is part of a long-term collaboration
between the London School of Hygiene & Tropical Medi-
cine, the Institute of Child Health and the Kintampo
Health Research Centre (KHRC) in the Ghana Health
Service. Newhints is based at KHRC and covers seven
contiguous districts in the Brong Ahafo Region of Ghana:
Kintampo North, Kintampo South, Wenchi, Tain, Techi-
man, Nkoranza North, and Nkoranza South. These dis-
tricts also formed the study area for the vitamin A and
maternal mortality "ObaapaVitA" trial. More than 15,000
babies are born within this area each year; the neonatal
mortality rate is 31 per 1000 live births and approximately
50% of births occur at home[12].
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tional ecological zone, and has two distinct rainy seasons
from April to July and from September to October. The
area is densely populated (175 people/square mile) with a
total population of approximately 600,000 persons, and
more than 100,000 women of reproductive age. The
annual population growth rate is currently 3.1%; only 10%
of the population in the study area live in the urban dis-
trict administrative centres. The rural population lives in
compounds, containing houses with mud walls, and
thatch or aluminium roofs, in dispersed villages sur-
rounded by farming land. The main occupation is subsis-
tence farming and the main crops are yam, maize and
millet. The population is multi-ethnic and education lev-
els are low.
There are 4 district hospitals (3 hospitals are currently
shared by two districts) that provide clinical (outpatient
and inpatient) and maternity services and act as the first
referral point for sub-district and community based
health care facilities. The sub-district has an administra-
tive centre located in a small town and usually has a
health centre that provides basic maternal and child
health (MCH) care. At community level there are a small
number of additional government health centres and pri-
vate facilities that provide basic MCH services. Each vil-
lage also usually has one or more traditional birth
attendants (TBAs), trained or untrained, one or more
community-based surveillance volunteers (CBSVs) who
assist the DHMT with registration of births, mobilisation
of the community for activities such as national immuni-
sation days, registration of deaths, and with community
child welfare outreach clinics. Other community based
health care providers are chemists/drug sellers and tradi-
tional healers.
Overview of Trial Design
The Newhints intervention is being evaluated through a
cluster randomised controlled trial design. The clusters
are Newhints zones which correspond to supervisory
units of about 8-12 CBSVs. There are 98 Newhints zones
in total; 49 zones randomised for implementation of the
Newhints intervention, with the other 49 zones acting as
controls. The trial planning started in October 2006. The
Newhints intervention was developed and fully imple-
mented in the intervention zones by the end of 2008.
Impact data on neonatal mortality and newborn care
practices is being collected through ongoing surveillance
of all women of child-bearing age and their infants in the
trial area, and will be based on approximately 15,000
babies born from 1 January 2009. Detailed process, cost
and cost-effectiveness evaluations are also being carried
out. Data collection is expected to be completed in April
2010 and analysis will take place throughout 2010.
The Newhints Intervention
Newhints is an integrated intervention package (Figure 1)
based on extensive formative research [13], and devel-
oped in close collaboration with the District Health Man-
agement Teams (DHMTs), with input from key national
neonatal policy makers and programme coordinators,
and experts in neonatal health, behaviour change com-
munication and working with community volunteers.
DHMT collaboration
The Newhints intervention was developed in close col-
laboration with the DHMTs. Each DHMT designated a
member to be the liaison person for all Newhints-related
activities, to attend regular DHMT-Newhints meetings
involving all districts in the trial area, and to take a lead
role in introducing the Newhints intervention to the
health facilities and communities. The DHMTs receive a
small quarterly budget to cover costs of their participa-
tion. In addition, there are 2 district project supervisors
(DiPS) based in each DHMT; they participate in other
community DHMT activities, such as the national immu-
nization campaigns, as well as supervising the CBSVs. All
DiPS are provided with a motorbike and fuel and mainte-
nance costs are covered by the project.
Home visits by CBSVs
The core component of the intervention is five home vis-
its by CBSVs to pregnant women and their babies. Two
visits are targeted during pregnancy and three during the
first week of life of the neonate; the timing and focus of
each visit is summarised in Table 1. The visits involve
family members as well as the pregnant woman and use
storytelling and a counselling and problem solving
approach concerning key gaps in care practices identified
during the formative research. At the first visit after birth,
the CBSV weighs the baby, and advises mothers of low
birthweight (LBW) babies (<2500 g) about a package of
special care comprising skin to skin contact, frequent
breastfeeding, wiping rather than bathing the baby, and
special attention to hygiene. The CBSVs also refer any
very LBW babies (<1500 g) to hospital. In addition, the
CBSVs assess all babies at each of the three postnatal vis-
its and refer to hospital any baby who has one or more of
the following danger signs: not able to feed since birth or
stopped feeding well; convulsed or fitted since birth; fast
breathing: two counts of 60 breaths or more in one min-
ute; chest in-drawing; high temperature: 37.5°C or more;
very low temperature: 35.4°C or less; only moves when
stimulated; yellow soles; pus from umbilical stump or red
umbilical stump; pus from eyes; and boils with pus. They
conduct follow-up visits for referred babies within 24
hours, and an additional postnatal visit to LBW babies at
the end of the second week.
CBSV Materials and Equipment
CBSVs are provided with a set of materials that aim to
motivate and give credibility as well as serving functional
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Newhints polo shirt; manual; workbook; counselling and
assessment cards; tubular weighing scales and slings; dig-
ital timers to measure respiratory rates; digital thermom-
eters; cotton rolls and 70% ethanol for disinfecting
thermometer; referral slips; and family cards to record
appointments, births, birthweights and referrals and
which also have key message reminders. CBSVs, who
work in areas that are too large to be covered easily on
foot, are provided with a bicycle.
Training of CBSVs
It was decided that this complex intervention would be
best introduced to the CBSVs in two phases of training
with phase 1 focusing on identifying pregnant and deliv-
ered women in the community, behaviour change com-
munication, essential newborn care and on the use of
counselling cards. Three-day training courses with 30-40
CBSVs per course took place during February and March
2008 in locations accessible to the CBSVs such as schools,
churches and health facilities with CBSVs travelling to the
training venue each day for the 3-day course. Training
was led by teams of 2-4 Newhints staff, who had attended
a training of trainers (ToT) session conducted by the
Newhints clinician (AM), who had himself attended a
UNICEF run training of trainers course. It utilized a com-
petency based approach. Facilitator and participant
guides and a set of overheads were developed by adapting
various WHO, UNICEF and SNL manuals.
Phase 2 training focussed on weighing, assessing the
newborn for danger signs and referring, and on promot-
ing special care for low birthweight babies; it also
included a review of phase 1 activities. It started with a
ToT workshop conducted by Dr Rajiv Bahl (WHO) in
Accra in May 2008 for eight Newhints trainers. The con-
tent of the training package was finalised during the ToT
to be delivered over four days with a maximum of 25 par-
ticipants per session, and involving practical sessions
where CBSVs could practise weighing and assessing new-
borns. The Newhints district project supervisors (DiPS)
were trained at the end of May 2008. The second phase of
training for the CBSVs started on June 2, and was com-
pleted on 12 July 2008. In addition, CBSVs received a 2
Figure 1 Newhints integrated intervention package details.
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beginning of November 2008. A total of 406 CBSVs were
fully-trained, with all intervention communities having
one or more trained CBSVs.
Supervision of CBSVs
There are two District Project Supervisors (DiPS) based
in each DHMT, who have been trained in supervisory
skills and who are responsible for supervising CBSVs in
their catchment areas. They aim to visit each of their
CBSVs at least once a month to directly observe a home
visit and to problem-solve any issues. They also aim to
hold group meetings every two to three months where
CBSVs can share their experiences and problems are dis-
cussed. In addition, they hold meetings with community
leaders to provide feedback and stimulate interest in the
intervention. They also carry out regular checks on all
CBSV equipment and arrange replacements as necessary.
A set of materials have been developed to support super-
vision including a workbook to record activities and
issues raised, a monthly CBSV tally sheet to record visits
carried out and participation in group meetings, and
forms to record detailed observation of home visits.
Incentives
It was decided during the formative research that provid-
ing a monthly monetary incentive would be key in keep-
ing CBSVs active and maintaining motivation. An
amount of 5 Ghana cedis per month (approximately $5)
was determined in discussion with national and district
level representatives of the Ghana Health Service to be
both sustainable and sufficient to motivate CBSVs. These
monthly incentives are distributed by the DiPS during
supervisory visits.
Hospital essential newborn care strengthening
As CBSVs are trained to refer very low birthweight and
sick babies, and as the formative research identified some
inadequacies in the current provision of newborn care, it
was considered essential to update skills and knowledge
of staff in the main health facilities. In response to a joint
request from the DHMTs and Newhints team, endorsed
by the National Reproductive and Child Health Coordi-
nator, WHO conducted a national ToT workshop in
"Strengthening Essential Newborn Care in Health Facili-
ties" in Accra in July 2008. Two training workshops were
then held later in July at Techiman and at Nkoranza hos-
pitals for staff from the 10 largest health facilities, includ-
ing the district hospitals, that provide care and services
for newborns; these were facilitated by the Newhints cli-
nician (AM) and others trained at the national workshop.
Supportive activities
There are several supportive actions to promote the
intervention and ensure women receive consistent advice
from health facility staff, traditional birth attendants




- Promote and plan for a facility 
delivery
- Plan for a clean home delivery
- Plan for emergencies
- Sleep under a treated bed net
Supporting messages:
- Encourage antenatal care 
attendance
- Seek care for maternal danger signs
3rd trimester - Dry, wrap & breastfeed immediately 
after delivery (plus 2nd assistant 
during home delivery to facilitate this)
- Delay bathing for at least a day
Day of birth - Weigh and assess the baby for 
danger signs
- Refer very low birth weight (LBW) & 
potentially sick babies to hospital
- Encourage exclusive breastfeeding 
(EBF)
- Encourage good thermal care (bath 
with warm water, dry immediately 
and wrap well)
- Encourage special care for LBW 
babies (Skin to skin contact, delay 
bathing at least 3 days, hygiene, 
frequent breastfeeding)
Day 3 - Assess baby for danger signs & refer 
sick babies
- Reinforce EBF, thermal care
- Teach newborn danger signs & 
encourage prompt care-seeking
Day 7 - Assess baby for danger signs & refer 
sick babies
- Reinforce EBF, thermal care, prompt 
care-seeking
- Encourage bed net use, 
immunisations
Other visits - Follow-up visits within 24 hours for 
referred babies
- Visit at 14 days for LBW babies
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has their own protocol.
• Health facility sensitization: The DHMTs
organised meetings in each district during September
and October 2007 and invited sub-district teams, and
those in charge of health facilities together with the
public health nurses and midwives who help in the
delivery of babies and who take care of pregnant
mothers. At these meetings, the Newhints team out-
lined the proposed intervention and discussed its
implications for the health facilities. This included a
detailed discussion of the newborn care practices
being promoted in order to harmonise messages
between the trial and health facility staff, and feed-
back on findings of the health facility survey con-
ducted during the formative research. In addition, the
six district hospitals were visited in June and July 2008
in order to refresh the memory of health workers in
the hospital regarding Newhints, to introduce and
explain the referral strategy and the use of the referral
slip, and to discuss prioritization of babies with refer-
ral slips.
• Community leaders sensitization: Introductory
visits were made during December 2007 and January
2008 to all 191 communities in the intervention zones
by teams of one DHMT representative, one Newhints
supervisor (DiPS) and one NewHints researcher.
Appointments were made with community leaders,
who invited key members of their community; the
CBSVs also attended. The meetings aimed to garner
community leader support for Newhints activities,
and to raise the profile of the CBSVs. They lasted 1 to
2 hours and took the form of presentation, demon-
stration and discussion. The questions that were
raised centred on issues around implementation,
community involvement, financial support and the
content of Newhints intervention messages. These
fed into the CBSV training manual and the TBA sen-
sitization and community-wide meeting (durbar) pro-
tocols. The community leaders were formally asked if
they would like their CBSVs to carry out Newhints
activities; all agreed.
• TBA sensitization: A series of TBA sensitisation
meetings were held in February 2008 in each district
to garner their support for Newhints activities, to
help ensure that TBA advice would not conflict with
Newhints advice, and to discuss behaviours that
TBAs may control such as hand washing, early bath-
ing and immediate drying and wrapping. All TBAs
(trained and untrained) who were known to be active
within the intervention communities were invited.
• Community durbars: Community wide meetings
were organised by the DHMT-Newhints teams dur-
ing July and August 2008, and chaired by the commu-
nity chiefs. Their purpose was to introduce the
importance of newborn care to the community, to
explain the rationale, content and structure of the
Newhints intervention, to discuss the importance of
community support for its success, and to present the
fully trained CBSVs with their Newhints T-shirt, bag
and certificate.
Mapping zones
An inventory was carried out of all CBSVs working in the
trial area and data collected on their socio-economic sta-
tus, level of education, and current workload and sched-
ule. The trial area was then divided into a total of 98
supervisory zones. Their boundaries were defined in dis-
cussion with the DHMTs, based on feasibility of coverage
within the zone by bicycle, size of communities, geo-
graphical access from one community to another, and the
total number of CBSVs covered aiming for about 8 CBSVs
per zone. There were a few larger zones as villages were
never divided between zones and some had more than 8
resident CBSVs, and a few smaller ones in geographically
separated communities. The large towns were divided
into zones of geographical non-contiguous areas, based
on size, population and already established CBSV work
areas.
Randomisation
Meetings were held in each district in November 2007 to
introduce the Newhints trial to all CBSVs, to explain the
proposed randomization process and to obtain their
cooperation and support for this; 686 CBSVs (91%)
attended. Forty-nine zones were then selected at random
for implementation of the Newhints intervention, with
the other 49 zones acting as control. This was carried out
by an independent epidemiologist using restricted strati-
fied randomisation to ensure balanced numbers of inter-
vention and control zones in each of 10 strata. These
were the four large towns (Kintampo, Nkoranza, Techi-
man and Wenchi) and the six districts (Kintampo North,
Kintampo South, Nkoranza, Tain, Techiman and Wenchi)
minus these towns; note this took place before Nkoranza
was divided into two districts, Nkoranza North and Nko-
ranza South. Restricted randomisation used available sur-
veillance data to ensure that intervention and control
arms were also balanced with respect to the following cri-
teria: absolute differences of less than 2/1000 live births
for neonatal mortality rates, less than 2.5% for the per-
centage of deliveries in a health facility, and less than 2.5%
for the percentage of deliveries in a private hospital, in
each of 2004, 2005 and 2006. An additional selection cri-
terion was to ensure that the 4 pilot zones (which had
been chosen at random) were allocated to the interven-
tion group.
Kirkwood et al. Trials 2010, 11:58
http://www.trialsjournal.com/content/11/1/58
Page 7 of 11Intervention Zones
The Newhints intervention as described above was
implemented in the 49 intervention zones. All pregnant
women and newborns living in these zones were there-
fore potential recipients of the intervention receiving
home visits from CBSVs, in addition to routine maternal
and child health (MCH) care currently available.
Control Zones
Pregnant women and newborns living in the control
zones continued to benefit from the routine MCH care
currently available, which includes: antenatal clinics
(ANC), Infant Welfare Clinics (IWC), access to free deliv-
ery with skilled attendants, access to TBA delivery and
care, and routine interactions with CBSVs concerning
outreach MCH and immunisation clinics. In addition
control zones benefitted from the hospital essential new-
born care strengthening and health facility sensitisation
that covered all facilities in the trial area.
Sample size
The sample size was determined by the primary outcome,
all cause neonatal mortality, using the baseline neonatal
mortality rate (NMR) of 31 per 1000 live births and the
intraclass correlation coefficient (ICC) of 0.0007256,
where the ICC[14] is defined as the ratio of the between
zone variation to the total variation. This suggests that a
total sample size of 15,200 livebirths would have 80%
power to detect a 25% reduction in NMR at the 5% signif-
icance level, 93% power to detect a 30% reduction and
60% power to detect a 20% reduction. This sample size
should be achieved by the number of livebirths that take
place in a year in the trial area. The evaluation will be
based on data collected for all babies born from 1 January
2009; this is 1 month after the intervention was fully
implemented, and 6 months after CBSVs started assess-
ing babies in July 2008 as well as counselling about new-
born care practices.
Impact evaluation
The primary outcomes are all cause neonatal mortality
and key care practices; these will be compared between
intervention and control zones. Secondary outcomes are
age and cause-specific neonatal mortality. All required
data are being collected through the surveillance system
of 4-weekly home visits to all women of reproductive age
established for the ObaapaVitA vitamin A and maternal
mortality trial that took place from December 2000-
October 2008[15]. This surveillance has been continued
for the Newhints trial.
Resident fieldworkers are responsible for a fieldwork
area (FWA) of four contiguous clusters of compounds,
visiting women in one cluster per week over a 4-weekly
cycle. Each week, fieldworkers receive an updated listing
of women to be visited that week, and their pregnancy
status, arranged by compound. A MONTH form is com-
pleted for each woman, and includes questions on
whether she was present, if not whether she had died, any
morbidity requiring treatment outside the home or hos-
pitalisation, her pregnancy status, and a question on the
outcome of the pregnancy, completed when a pregnancy
ends. There is a scheduled 4-week fieldwork break each
year over Christmas.
Other forms are completed as required. A PROFILE
form collecting socio-demographic information is com-
pleted as soon as a woman reports that she is pregnant. A
birth results in: a BIRTH form collecting data on preg-
nancy, delivery, the baby (or babies), newborn care prac-
tices and contact with CBSVs; and monthly INFANT
form(s) completed until the baby reaches 12 months of
age collecting data on their status, and exposure to key
child survival interventions. These forms were revised to
ensure that they capture data on practices promoted by
the Newhints intervention.
Verbal post-mortems (VPMs) are carried out for all
neonatal deaths in the trial area. A surveillance supervi-
sor visits the household and interviews the mother or
care-taker about the circumstances surrounding the
death, including an open history, and specific questions
on symptoms. All VPMs are reviewed by two experienced
doctors, who independently code the likely cause of
death. If they disagree, the form is reviewed by a third
doctor; if their diagnosis matches one of the other two,
this is accepted. If not, they meet to discuss the case and
attempt to reach agreement. If this is not possible the
cause is coded as unable to be determined.
Data Management
The trial impact evaluation outcomes will be derived
from the surveillance database which was established in
2000 using Visual FoxPro (version 6.0 Microsoft Corp
Seattle WA USA), and which was modified to include
new data collection forms developed for Newhints. All
forms are manually checked for completeness and consis-
tency before they leave the field, collected and processed
on a weekly basis. Independent double data entry with
verification is carried out together with range and consis-
tency checks, and inter-table consistency checks. Any
queries identified are resolved promptly by the trial man-
agement team, and the database updated. New data are
added to the database within 4 weeks of collection, and in
time for the updated data to be used to generate field list-
ings for the next 4-weekly visit. Copies of the surveillance
database will be made and frozen within three months
after the completion of the fieldwork.
Participant flow & comparability of treatment arms
A flow diagram will be completed showing the number of
zones, pregnancies, livebirths, neonatal deaths and loss to
follow-up in the intervention and control arms, together
with a map showing the locations of the intervention and
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compared with respect to the following variables: neona-
tal mortality rate, the percentage of skilled attendants at
delivery and percentage of deliveries occurring in health
facilities in 2007 (baseline); level of education of mothers,
their ethnic group of origin, marital status and parity, and
occupation (used as proxy indicator for the level of
income), since these are known either to be related to the
neonatal mortality rate or to effect peoples' knowledge,
attitudes and practices on neonatal care. No statistical
significance tests will be carried out on these compari-
sons [14,16]. However, analyses will be carried out both
including and excluding these potential a priori con-
founders.
Intention-to-treat analyses
The primary analysis for each outcome will be intention-
to-treat, where intention to treat is defined by a woman's
zone of residence. All analyses will account for the clus-
ter-randomised design using random effects logistic
regression and will be carried out both with and without
adjustment for potential confounders (see above); indi-
vidual-level methods are statistically more efficient than
cluster-level methods, and are preferred when a large
number of clusters have been randomised, as is the case
in this trial, as they readily allow adjustment for covari-
ates [16]. Quadrature checks will be carried out to con-
firm the reliability of the results; should these fail
generalized estimating equations (GEE) and robust stan-
dard errors will be used instead [16]. The estimated effect
of the intervention will be presented as a relative risk
together with a 95% confidence interval. The intraclass
correlation (ICC) and coefficient of variation (k) will be
reported. Random-effects logistic regression will also be
used to explore whether there are any differences in
impact of the intervention: between facility- and home-
based deliveries; between urban and rural areas; and
between the four zones included in the pilot and the
other intervention zones.
Secondary analyses
With a public health intervention, such as Newhints, it is
impossible to ensure every eligible recipient receives the
intervention in exactly the way it was intended. Thus it is
likely that only a proportion of pregnant women residing
in intervention zones will receive all five home visits at
the timing intended; others may not have received any, or
fewer visits, or visits later than intended, in particular the
first post-natal visit may not have taken place within 24
hours as intended. Secondary analyses will therefore also
be carried out to examine whether the impact of the
intervention varies according to the number and timing
of home visits each woman has received, and the average
quality of the intervention delivered in the zone, as
assessed by the process indicators measured on a sub-
sample of women (see below). This will be explored both
using individual quality indicators and by dividing inter-
vention zones into quintiles, based on a quality index
derived using principle component analysis [17].
Process evaluation and intervention monitoring
All aspects of the intervention process are being fully
documented and evaluated on an ongoing basis using a
variety of methods and data sources:
• CBSV Programme: The CBSV database will provide
data on the following: Profile of the CBSVs (age, gen-
der, ethnicity); Number (& %) of CBSVs trained, &
retrained; CBSV attrition and replacement rate;
Number (& %) of CBSVs who received incentive pay-
ment each month. This will be supplemented by in-
depth interviews with a sample of CBSVs, and issues
raised during group meetings.
• Supervisor performance: This is being assessed on
an ongoing basis using data collected from the DiPS
workbooks, monthly log sheets and observations of
supervisory visits by their supervisors. Indicators
include: % CBSVs who received supervisory visits
each month; % CBSVs who were directly observed
during supervisory visits each month; % of CBSVs
who attended group meetings in each 2 monthly
period; frequency of supervisory visits per CBSV; Fre-
quency of group meetings per CBSV. In addition
supervisor performance will be assessed by % super-
visory visits observed by a senior newhints team
member that were conducted according to protocol;
and % supervisors scoring at least 80% in test assess-
ing their knowledge of counselling cards and proto-
col.
• Coverage and timing of CBSV visits: Detailed infor-
mation concerning CBSV visits is collected on a PRO-
CESS form administered to a random subsample of
200-300 recently delivered women each month. Indi-
cators include: % recently delivered women who
received full complement of 5 home visits; % visited
according to schedule; % who received ante-natal vis-
its; % who received post-natal visits; % who received
first postnatal visit within 24 hours after delivery.
• Quality of CBSV visits: This will be assessed using
the detailed DOS reporting forms completed by the
supervisors during their observations of home visits,
supplemented by information collected on the PRO-
CESS form. The % CBSVs delivering the intervention
according to protocol will be reported for the follow-
ing: counselling cards & interactions; weighing &
assessment for danger signs; referral & care seeking;
correct card filling.
In-depth interviews and focus group discussions will
also be carried out with a range of respondents (recently-
delivered women, their families, CBSVs, TBAs, health
facility staff ) to explore all aspects of the intervention
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studies will focus on the provision of special care for low
birthweight babies, and the assessment and referral of
sick and very low birthweight babies.
Summary statistics and graphs showing trends over
time will be compiled for all the process indicators, and
determinants of quality of intervention delivery explored.
The transcripts from in-depth interviews and focus
group discussions will be formally analyzed using Nvivo
software. Key analytical categories will be identified and
the interviews systematically indexed into these catego-
ries and interpreted in order to make recommendations
concerning intervention implementation, identify factors
contributing to success, document barriers encountered
and strategies adopted to tackle them, and identify issues
important for scaling up.
Cost and cost-effectiveness evaluation
A detailed costing of the development, set-up, and imple-
mentation of the Newhints intervention is being carried
out with the following objectives: to estimate cost per life
saved, if Newhints successfully reduces neonatal mortal-
ity; to estimate the incremental cost-effectiveness of
Newhints relative to current practice, and compared with
other newborn health interventions (in Ghana and else-
where); to evaluate the financial sustainability (measured
in terms of incremental budget implications) of the pro-
gramme for the DHMTs; and to model the costs of scal-
ing-up to regional/national levels. Both financial and
economic costs will be considered. Formative research
costs will be included as programme development costs;
however, all other research costs will be excluded. A pro-
vider perspective will be taken and costs up to district
level will be included.
Financial cost data will be collected from a variety of
sources including itemized project accounting records,
activity diaries, and semi-structured interviews and time
sheets to determine the time allocation of Newhints team
members between research and programme activities.
The incremental costs of increased health facility utiliza-
tion attributable to the intervention will be estimated by
combining utilization data from the BIRTH and INFANT
forms with data extracted from hospital records and
direct observation in health centres on the quantities of
drugs and supplies used for deliveries and newborn
admissions, and unit cost data obtained from hospital
pharmacists and regional medical stores. The economic
cost of CBSV time will be quantified using information
on the number and average duration of CBSV visits and
other Newhints activities per month extracted from
CBSV records, DOS and PROCESS forms, while in-depth
interviews with CBSVs will explore the opportunity cost
of this time, including possible seasonal variations.
Informed consent
Informed consent was sought in late 2007 from all
women of reproductive age living in the intervention and
control zones for permission to use their surveillance
data for the evaluation of NewHints, in addition to its use
for the ObaapaVitA trial. Resident surveillance fieldwork-
ers read an information sheet and consent form to the
women in their own local language and checked for
understanding before requesting consent. Agreement
was indicated by signature or other imprint on prepared
consent forms. Women were assured of their right to
refuse consent without prejudice to their position in the
ongoing ObaapaVitA trial (which finished in October
2008), or to any community or health services received.
There were no refusals. This consent procedure is being
applied on an ongoing basis for new women who move
into the trial area and are recruited into the surveillance
system. In addition, in the intervention zones, the CBSVs
will, as per usual practice, obtain permission to make
home visits from each pregnant woman identified.
Individual informed consent is also being sought from
those selected for in-depth interviews and focus group
discussions as part of the process and cost evaluations,
and will follow a similar procedure. Interviewers read an
information sheet and consent form to potential partici-
pants in their own local language and check for under-
standing before consent is requested. Agreement to
participate in the interview is indicated by signature or
other imprint on prepared consent forms. The individ-
ual's right to refuse consent or to stop the interview at any
time after consent has been given will be preserved with-
out prejudice to their position in other ongoing research,
or to any community or health services received. They
will not be required to provide explanation for such deci-
sions.
No informed consent is being obtained from the DiPS
or the CBSVs regarding collection of routine data from
workbooks to monitor progress, or for recording obser-
vation of home visits, since such monitoring is an integral
part of normal supervision activities, necessary to ensure
the integrity of the intervention.
Confidentiality of all data collected is maintained at all
times and is accessible only to senior project staff and to
the trial monitoring committees. This includes informa-
tion collected during the process evaluation except where
it relates to routine monitoring of performance of CBSVs
and supervisors. All women and babies in the surveil-
lance database are identified by a unique ID number. The
database is stored on a security protected server, with
password access only by senior project staff. The data
forms are stored in secure record stores and will be kept
for a minimum of 5 years after the end of the trial.
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The Trial Steering Committee (TSC) has 12 external
members, chosen to facilitate dissemination and uptake
of any findings within Ghana as well as to provide techni-
cal support; members include key policy makers from the
Ghana Health Service at national and regional level,
national WHO and UNICEF representatives and advisers
with expertise in obstetrics, demography, statistical
methods, clinical trials and health services research. It is
also attended by the principle investigators, members of
the trial management team and representatives from the
participating DHMTs and funding bodies. The Data
Monitoring and Ethics Committee (DMEC) has five
members, with expertise in epidemiology and medical
statistics (including the design and analysis of cluster ran-
domised trials), obstetrics, maternal health and commu-
nity medicine. Both committees meet annually to
examine trial conduct and progress and to advise the trial
management team. The DMEC are not carrying out any
interim analyses, as the Newhints intervention is health
promoting and does not involve any drugs or medical
procedures, and as the evaluation is based on births
occurring over a period of just one year.
Ethical approval
The trial protocol was reviewed and approved by the eth-
ics committees of the Ghana Health Services, the Kin-
tampo Health Research Centre and the London School of
Hygiene and Tropical Medicine. It is registered with clin-
icaltrials.gov (identifier NCT00623337).
Dissemination of Trial Findings
Trial findings will be shared promptly with the Technical
Steering Committee, and discussed with the local District
Health Management Teams. Local dissemination meet-
ings with the study populations will be held. A CD will be
compiled containing all intervention materials plus a
detailed implementation evaluation report of lessons
learned and shared widely. Policy briefs will be prepared
and circulated nationally and internationally to relevant
policy and donor organisations, and if possible a national
workshop held to discuss the findings, lessons learnt con-
cerning implementation and policy implications.
Trial findings will also be disseminated in scientific
meetings and papers on: the impact of the intervention
on neonatal mortality; impact on neonatal care practices;
any intervention differences by place of delivery or
between rural and urban zones; process outcomes, and
lessons learned concerning working with volunteers,
supervision, monitoring performance; training volun-
teers to assess babies and how well do they do; strategies
to promote coverage; factors influencing response to spe-
cific care recommendations including special care for low
birthweight babies and referrals; and cost-effectiveness of
the intervention.
Requests to analyse or publish data from persons exter-
nal to the study will be entertained 3 years after the data-
bases are frozen. The requesting researcher in addition to
at least 2 persons from within the project team will
author such publications and acknowledgement will be
given to the project team including the collaborators.
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